v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net income $ 767,000 $ 845,000
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 665,000 332,000
Amortization of deferred commissions 340,000 293,000
Stock-based compensation 1,199,000 969,000
Deferred income taxes 138,000 48,000
Unrealized (gains) losses on strategic investments (360,000) (5,000)
Other 63,000 67,000
Changes in operating assets and liabilities, net of effect of business combinations:    
Accounts receivable 471,000 599,000
Deferred commissions (376,000) (291,000)
Prepaid expenses and other assets (118,000) (222,000)
Accounts payable 9,000 133,000
Deferred revenue (382,000) (264,000)
Accrued expenses and other liabilities (159,000) (111,000)
Net cash provided by operating activities 2,257,000 2,393,000
Cash flows from investing activities:    
Purchases of property and equipment (255,000) (395,000)
Business combinations, net of cash acquired (8,776,000) (76,000)
Purchases of other intangibles 0 (34,000)
Purchases of marketable securities (426,000) (2,322,000)
Purchases of strategic investments (178,000) (138,000)
Sales and maturities of marketable securities 2,528,000 2,281,000
Other 2,000 44,000
Net cash used in investing activities (7,105,000) (640,000)
Cash flows from financing activities:    
Proceeds from borrowings on senior notes, net of discount and issuance costs 3,944,000 0
Proceeds from term loan, net of issuance costs 3,991,000 0
Repayment of term loan (4,000,000) 0
Proceeds from issuance of commercial paper, net of discount 3,534,000 0
Repayments of commercial paper (1,472,000) 0
Proceeds from employee stock plans 154,000 153,000
Repurchases of common stock (2,225,000) (659,000)
Taxes paid related to net share settlement of equity awards (281,000) (438,000)
Other (7,000) 0
Net cash provided by (used in) financing activities 3,638,000 (944,000)
Foreign currency effect on cash, cash equivalents and restricted cash (5,000) 14,000
Net change in cash, cash equivalents and restricted cash (1,215,000) 823,000
Cash, cash equivalents and restricted cash at beginning of period 3,732,000 2,310,000
Cash, cash equivalents and restricted cash at end of period 2,517,000 3,133,000
Cash, cash equivalents and restricted cash at end of period:    
Cash and cash equivalents 2,503,000 3,124,000
Restricted cash included in prepaid expenses and other current assets 9,000 9,000
Restricted cash included in other assets 5,000 0
Total cash, cash equivalents and restricted cash shown in the condensed consolidated statements of cash flows 2,517,000 3,133,000
Supplemental disclosures of other cash flow information:    
Interest paid 29,000 11,000
Income taxes paid, net of refunds 130,000 129,000
Non-cash investing and financing activities:    
Property and equipment included in accounts payable, accrued expenses and other liabilities 58,000 40,000
Fair value of common stock issued for business combinations $ 0 $ 434,000